These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 34419519)

  • 21. [Fragility fracture in the Chronic Kidney Disease (CKD)].
    Fusaro M; Aghi A; Mereu MC; Giusti A
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors and clinical prediction models for osteoporosis in pre-dialysis chronic kidney disease patients.
    Kuang C; Shang J; Ma M; Huang S; Yan B; Zhong Y; Guan B; Gong J; Liu F; Chen L
    Ren Fail; 2024 Dec; 46(2):2361802. PubMed ID: 38874080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.
    Amerling R; Harbord NB; Pullman J; Feinfeld DA
    Blood Purif; 2010; 29(3):293-9. PubMed ID: 20090316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic kidney disease and bone fracture: a growing concern.
    Nickolas TL; Leonard MB; Shane E
    Kidney Int; 2008 Sep; 74(6):721-31. PubMed ID: 18563052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.
    Malluche HH; Monier-Faugere MC; Blomquist G; Davenport DL
    Osteoporos Int; 2018 Jan; 29(1):125-134. PubMed ID: 28993865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and therapeutic decisions of osteoporosis in chronic kidney disease.
    Jørgensen HS; Moe S; Nickolas TL
    J Bone Miner Res; 2024 May; 39(5):531-535. PubMed ID: 38630872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of bone turnover markers to predict mineral and bone disorder in men with pre-dialysis non-diabetic chronic kidney disease.
    Davina JJ; Priyadarssini M; Rajappa M; Parameswaran S; Sahoo J; Mohan Raj PS; Revathy G; Palanivel C; Marella MG
    Clin Chim Acta; 2017 Jun; 469():195-200. PubMed ID: 28414058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone Fragility Fractures in CKD Patients.
    Pimentel A; Ureña-Torres P; Bover J; Luis Fernandez-Martín J; Cohen-Solal M
    Calcif Tissue Int; 2021 Apr; 108(4):539-550. PubMed ID: 33219822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic kidney disease and the skeleton.
    Miller PD
    Bone Res; 2014; 2():14044. PubMed ID: 26273531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mineral bone disorder and osteoporosis in hemodialysis patients.
    Slouma M; Sahli H; Bahlous A; Laadhar L; Smaoui W; Rekik S; Gharsallah I; Sallami M; Moussa FB; Elleuch M; Cheour E
    Adv Rheumatol; 2020 Feb; 60(1):15. PubMed ID: 32102689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of fracture risk in chronic kidney disease.
    Torres PAU; Cohen-Solal M
    J Nephrol; 2017 Oct; 30(5):653-661. PubMed ID: 28386879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic kidney disease is associated with low BMD at the hip but not at the spine.
    Bezerra de Carvalho KS; Vasco RFV; Custodio MR; Jorgetti V; Moysés RMA; Elias RM
    Osteoporos Int; 2019 May; 30(5):1015-1023. PubMed ID: 30693381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism.
    Evenepoel P; Cunningham J; Ferrari S; Haarhaus M; Javaid MK; Lafage-Proust MH; Prieto-Alhambra D; Torres PU; Cannata-Andia J; ; ;
    Osteoporos Int; 2021 Dec; 32(12):2397-2405. PubMed ID: 34129059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone and kidney disease: diagnostic and therapeutic implications.
    Jamal SA; West SL; Miller PD
    Curr Rheumatol Rep; 2012 Jun; 14(3):217-23. PubMed ID: 22350608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic kidney disease and osteoporosis: evaluation and management.
    Miller PD
    Bonekey Rep; 2014; 3():542. PubMed ID: 24991405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy for patients with CKD and low bone mineral density.
    Ott SM
    Nat Rev Nephrol; 2013 Nov; 9(11):681-92. PubMed ID: 24100401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease.
    Iwasaki Y; Kazama JJ; Fukagawa M
    Biomed Res Int; 2017; 2017():3485785. PubMed ID: 28421193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone Disorders in Chronic Kidney Disease: An Update in Diagnosis and Management.
    Babayev R; Nickolas TL
    Semin Dial; 2015; 28(6):645-53. PubMed ID: 26332760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing bone mineralisation in children with chronic kidney disease: what clinical and research tools are available?
    Lalayiannis AD; Crabtree NJ; Fewtrell M; Biassoni L; Milford DV; Ferro CJ; Shroff R
    Pediatr Nephrol; 2020 Jun; 35(6):937-957. PubMed ID: 31240395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.